AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Recordati Industria Chimica e Farmaceutica

Report Publication Announcement Jul 31, 2023

4056_10-q_2023-07-31_d0ee1b25-3cb8-477f-acc4-88c8780f77b4.pdf

Report Publication Announcement

Open in Viewer

Opens in native device viewer

RECORDATI: PUBLIC DISCLOSURE - INTERIM FINANCIAL STATEMENTS

Milan, 31 st July 2023 – Following the press release issued on 28th July 2023, please be informed that the Interim financial statements at 30th June 2023, approved by the Board of Directors on 28th July 2023, together with the Independent Auditors' Report on the interim condensed consolidated financial statements at 30th June 2023 are available to the public, as of today, at the Company's registered office, on the Company's website (www.recordati.com) and on the storage mechanism ().

Recordati (Reuters RECI.MI, Bloomberg REC IM) is an international pharmaceutical group listed on the Italian Stock Exchange (ISIN IT 0003828271) uniquely structured to bring treatment across specialty and primary care, consumer healthcare, and rare diseases. We believe that health, and the opportunity to live life to the fullest, is a right, not a privilege. We want to support people in unlocking the full potential of their life. We have fully integrated operations across research & development, chemical and finished product manufacturing through to commercialisation and licensing. Established in 1926, Recordati operates in approximately 150 countries across EMEA, Americas and APAC regions. At the end of 2022, Recordati employed more than 4,300 people and consolidated revenue of1,853.3 million. For more information, please visit www.recordati.com.

Investor Relations Federica De Medici +39 02 48787146 e-mail: [email protected] Investor Relations Lucia Abbatantuoni +39 02 48787213 e-mail: [email protected] Media Relations Brunswick: Barbara Scalchi / Andrea Mormandi +39 02 9288 6200 e-mail: [email protected]

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.

Registered Office Via Matteo Civitali, 1 20148 Milano, Italy Tel. +39 02 487871 Fax +39 02 40073747 www.recordati.com

Share Capital € 26.140.644,50 fully paid-up Milano, Monza, Brianza and Lodi Comp. Reg. No. 00748210150 Tax Code/VAT No. 00748210150 Milano R.E.A. No. 401832

Company subject to the Management and Coordination Activity of Rossini Luxembourg S.àr.l

Talk to a Data Expert

Have a question? We'll get back to you promptly.